Nikki
Nikki Cheng, Prairie Village, KS US
Patent application number | Description | Published |
---|---|---|
20150369796 | METASTASIS MIMETIC DEVICE - Implementations of the present invention relate to apparatuses, systems, and methods for constructing and using a metastatic mimetic device. The device includes at least one chamber with a gate structure that allows a channel to selectively allow fluid communication between an interior of the chamber and an exterior of the chamber. The channel includes a porous member extending across a cross-section of the channel to control flow rates or allow the mimetic device to replicate transport across a member. | 12-24-2015 |
Nikki Edleman, Pawling, NY US
Patent application number | Description | Published |
---|---|---|
20100112729 | CONTACT PATTERNING METHOD WITH TRANSITION ETCH FEEDBACK - A method for forming a contact hole in a semiconductor device and related computer-readable storage medium are provided, the method and program steps of the medium including measuring a percentage of oxygen in an etching chamber, and controlling the percentage of oxygen in the etching chamber to enlarge a temporary inner diameter near a top of the contact hole. | 05-06-2010 |
20110183443 | CONTACT PATTERNING METHOD WITH TRANSITION ETCH FEEDBACK - A method for forming a contact hole in a semiconductor device and related computer-readable storage medium are provided, the method and program steps of the medium including measuring a percentage of oxygen in an etching chamber, and controlling the percentage of oxygen in the etching chamber to enlarge a temporary inner diameter near a top of the contact hole. | 07-28-2011 |
Nikki Filipuzzi, Calgary CA
Patent application number | Description | Published |
---|---|---|
20160125296 | System and Method for Securing an Architectural Environment Against Crime and Minimizing Criminal Elements - A computer-implemented method is provided for analysing and designing a physical environment for discouraging criminal activity within the physical environment. The physical environment is assessed and risk factors are identified that make the physical environment vulnerable to criminal activity. In one embodiment, risks posed by the nature and location of the physical environment within a spatial footprint are calculated. Further, the physical environment is evaluated to identify physical elements of the environment that could make the structure vulnerable to criminal attacks. Risk scores assigned to all of these factors are then analyzed to generate a recommendation report for at least one of the physical elements. Deploying at least one of the recommendations in the report aids in improving a deterrent rating assigned to that physical element and subsequently integrity of the physical environment against criminal attacks. | 05-05-2016 |
Nikki Horwood, South Woodford GB
Patent application number | Description | Published |
---|---|---|
20110136868 | AGENTS FOR INHIBITING OSTEOCLASTOGENESIS AND/OR OSTEOCLAST ACTIVATION - Agents, which are both ceramide glucosyltransferase inhibitors and glucosidase inhibitors, may inhibit osteoclastogenesis and/or reduce osteoclast activation and, therefore, may be useful for osteolytic activity and bone loss in subjects with conditions, such as multiple myeloma. | 06-09-2011 |
Nikki Robinson, London GB
Patent application number | Description | Published |
---|---|---|
20080274060 | Therapeutic Foam - A foam is described for injection treatment of varicose veins. The foam comprises a sclerosant liquid, e.g. polidocanol solution, and a gas. The gas comprises xenon, optionally together with at least one other physiologically acceptable gas which is readily absorbed in the body or blood of a patient. The gas comprises only a minimal amount of gaseous nitrogen, between 0.0001% and 0.8%. | 11-06-2008 |
20100260007 | Preparation of therapeutic foam - Closed pouch comprising a wall defining an enclosed space containing carbon dioxide, and a pair of syringes contained within the enclosed space. The syringes are connected together by a syringe connector, and of the syringes contains a gas or gas mixture other than air, while the other contains a foamable liquid. Breakage of the syringe, connector and pumping of the syringes produces a foam useful in the treatment of varicose veins. | 10-14-2010 |
20140361045 | PREPARATION OF THERAPEUTIC FOAM - A device is described for facilitating the preparation of therapeutic foam e.g. for the treatment of varicose veins. A pressurised vial contains a sclerosant liquid, e.g., polidocanol solution, and a sterile gas which is readily absorbed by the body, e.g., carbon dioxide, oxygen or a mixture of these gases. The vial is provided either with a specialised stopper/seal into which a syringe nozzle may be inserted or alternatively a septum seal which may be penetrated by a hypodermic needle. The quantities of gas and liquid and the pressure in the vial are pre-set so that, on connection of a syringe to the vial, a predetermined volume of both gas and liquid is transferred to the syringe, with the intention that the syringe is then used to make a foam by known means. The use of the vial ensures that the ratio of gas to liquid in the foam is standardised, and also provides a convenient way of packaging the gas and liquid and of filling the syringe in a sterile manner. | 12-11-2014 |
Nikki Robinson, Uxbridge GB
Patent application number | Description | Published |
---|---|---|
20100203171 | Therapeutic Foam - A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurised canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimising the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed. | 08-12-2010 |
20130059923 | Therapeutic Foam - A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurised canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimising the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed. | 03-07-2013 |
Nikki Robinson, Haarlem NL
Patent application number | Description | Published |
---|---|---|
20090148490 | Preparation of Therapeutic Foam - A device is described for facilitating the preparation of therapeutic foam e.g. for the treatment of varicose veins. A pressurised vial contains a sclerosant liquid, e.g., polidocanol solution, and a sterile gas which is readily absorbed by the body, e.g., carbon dioxide, oxygen or a mixture of these gases. The vial is provided either with a specialised stopper/seal into which a syringe nozzle may be inserted or alternatively a septum seal which may be penetrated by a hypodermic needle. The quantities of gas and liquid and the pressure in the vial are pre-set so that, on connection of a syringe to the vial, a predetermined volume of both gas and liquid is transferred to the syringe, with the intention that the syringe is then used to make a foam by known means. The use of the vial ensures that the ratio of gas to liquid in the foam is standardized, and also provides a convenient way of packaging the gas and liquid and of filling the syringe in a sterile manner. | 06-11-2009 |
Nikki Robinson, Aberdeenshire GB
Patent application number | Description | Published |
---|---|---|
20140221501 | THERAPEUTIC FOAM - A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurised canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimising the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed. | 08-07-2014 |
20160101881 | THERAPEUTIC FOAM - A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurised canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimising the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed. | 04-14-2016 |
Nikki Robishaw, Seville, OH US
Patent application number | Description | Published |
---|---|---|
20140142307 | AZOLIUM AND PURINIUM SALT ANTICANCER AND ANTIMICROBIAL AGENTS - Singly and multiply charged imidazolium cations (ICs) have been identified as a class of chemical compositions that possess potent antineoplastic, antibacterial and antimicrobial properties. The imidazolium cations disclosed demonstrate greater or equivalent potency towards cancerous cells as the current clinical standard, cisplatin. These imidazolium cations, however, achieve this efficacy without any of the known toxic side effects caused by heavy metal-based antineoplastic drugs such as cisplati. | 05-22-2014 |
Nikki Verrills, Rothbury AU
Patent application number | Description | Published |
---|---|---|
20130183684 | PROTEIN BIOMARKERS FOR OBSTRUCTIVE AIRWAYS DISEASES - Provided herein are methods for the diagnosis of obstructive airways diseases such as asthma and chronic obstructive pulmonary disease, and the discrimination between such diseases based on the expression profiles of biomarker proteins and combinations of biomarker proteins. In particular embodiments the biomarker proteins are selected from ceruloplasmin, haptoglobin, hemopexin, - | 07-18-2013 |
Nikki Villegas-Mauter, Northglenn, CO US
Patent application number | Description | Published |
---|---|---|
20130132406 | Neuroimaging database systems and methods - Systems for and methods of utilizing a neuroimaging database are presented. The systems and methods include techniques for analyzing the pathophysiological basis of a chronic brain disease and/or the effectiveness of a treatment for a chronic brain disease, obtaining data for research of a chronic brain disease, searching for chronic brain disease symptoms identified in a clinical patient, searching a database by comparing the brain scan images of patients with suspected indications of chronic brain disease with other patients in the database to identify sets of patients with similar indications in their brain scan images, displaying brain scan information regarding a person, and using image pattern matching to analyze the pathophysiological basis of a chronic brain disease and/or the effectiveness of a proposed or previously administered treatment for a chronic brain disease. | 05-23-2013 |
20150039346 | NEUROIMAGING DATABASE SYSTEMS AND METHODS - Systems for and methods of utilizing a neuroimaging database are presented. The systems and methods include techniques for analyzing the pathophysiological basis of a chronic brain disease and/or the effectiveness of a treatment for a chronic brain disease, obtaining data for research of a chronic brain disease, searching for chronic brain disease symptoms identified in a clinical patient, searching a database by comparing the brain scan images of patients with suspected indications of chronic brain disease with other patients in the database to identify sets of patients with similar indications in their brain scan images, displaying brain scan information regarding a person, and using image pattern matching to analyze the pathophysiological basis of a chronic brain disease and/or the effectiveness of a proposed or previously administered treatment for a chronic brain disease. | 02-05-2015 |
Nikki White, Pontotoc, MS US
Patent application number | Description | Published |
---|---|---|
20150054315 | RECLINING AND OTTOMAN-EXTENDING CHAIR MECHANISM - A seating-unit mechanism includes various components that control a position of the seat and backrest and that control an extension and retraction of an ottoman and footrest. For example, the mechanism includes a linear actuator that controls a seat pitch (e.g., height and level of recline). In addition, the mechanism includes an ottoman-linkage drive mechanism, which might include a drive link or another linear actuator. | 02-26-2015 |